| Avapritinib in the Treatment of Unresectable or Recurrent Metastatic GIST Non-exon18 Mutations of PDGFRA (NCT05461664) | Xinhua Zhang, MD | 2022-07-10 |
| A Multicenter Study of Avapritinib Efficacy and Safety of Metastatic or Unresectable Gastrointestinal Stromal Tumors (NCT05464875) | Xinhua Zhang, MD | 2022-07-09 |
| Second-line Pharmacotherapy Patterns and Outcomes of Advanced Gastrointestinal Stromal Tumor: A Real-world Study (NCT05440357) | Xinhua Zhang, MD | 2022-07-01 |
| Gastrointestinal Anastomosis Using MonoPlus® Suture (NCT04811833) | Aesculap AG | 2022-07-01 |
| Liver Transplantation for Unresectable GIST Liver Metastases (NCT04825470) | Hospital Universitario Virgen de la Arrixaca | 2022-05-01 |
| Study on Integrated Nursing Strategy for Patients With Gastrointestinal Stromal Tumors After Targeted Therapy (NCT05665868) | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 2022-04-01 |
| Prediction of Postoperative Treatment Efficacy and Recurrence Risk of High-risk GIST Based on Liquid Biopsy MRD (NCT05408897) | Peking University People's Hospital | 2022-01-01 |
| A Study of Pimitespib in Combination With Imatinib in Patients With GIST (CHAPTER-GIST-101) (NCT05245968) | Taiho Pharmaceutical Co., Ltd. | 2021-12-01 |
| Ripretinib in Combination With Binimetinib in Patients With Gastrointestinal Stromal Tumor (GIST) (NCT05080621) | Deciphera Pharmaceuticals, LLC | 2021-11-01 |
| Ripretinib Used for Resectable Metastatic GIST After Failure of Imatinib Therapy (NCT05132738) | RenJi Hospital | 2021-08-01 |
| Study for Patients Previously Treated in Avapritinib Clinical Trials (NCT04825574) | Blueprint Medicines Corporation | 2021-05-21 |
| Ripretinib in Chinese Patients With Advanced GIST: a Real World Study (NCT05697107) | Peking University | 2021-05-20 |
| 68Ga-NOTA-RM26 PET/CT for the Detection of Gastrointestinal Stromal Tumor (NCT05001204) | Peking Union Medical College Hospital | 2021-05-01 |
| DNX-2440 for Resectable Colorectal Liver Metastasis (NCT04714983) | DNAtrix, Inc. | 2021-02-15 |
| Clinical Evaluation of Genetron D842V PCR Kit in GIST Patients (NCT05400018) | Genetron Health | 2020-11-20 |
| Targeted Agent Evaluation in Digestive Cancers in China Based on Molecular Characteristics (NCT04584008) | Peking University | 2020-09-23 |
| Efficacy and Safety of Famitinib Versus Sunitinib in the Treatment of Advanced Gastrointestinal Stromal Tumour Patients After Failure of Imatinib (NCT04409223) | Jiangsu HengRui Medicine Co., Ltd. | 2020-09-12 |
| DS-6157a in Participants With Advanced Gastrointestinal Stromal Tumor (GIST) (NCT04276415) | Daiichi Sankyo | 2020-05-08 |
| A Study of DCC-2618 (Ripretinib) In Patients With With Advanced Gastrointestinal Stromal Tumors (GIST) (NCT04282980) | Zai Lab (Shanghai) Co., Ltd. | 2020-04-23 |
| A Study of CS3007 in Subjects With Gastrointestinal Stromal Tumor (NCT04254939) | CStone Pharmaceuticals | 2019-08-15 |
| Role of Surgery in Patients With Focally Progressive Gastrointestinal Stromal Tumors (GISTs) After Imatinib Treatment (NCT03862768) | Shanghai Zhongshan Hospital | 2019-07-01 |
| Observational Study, for Quality Assessment, of Sarcoma in European and Latin American Multidisciplinary NETWORK (NCT04181970) | Grupo Espanol de Investigacion en Sarcomas | 2019-06-30 |
| Paclitaxel in Patients With GIST With Low P-glycoprotein Expression After Failure of at Least Imatinib and Sunitinib, and Regorafenib. (NCT03944304) | Asan Medical Center | 2019-05-27 |
| A Study of Avelumab In Combination With Axitinib in Patients With Unresectable/Metastatic Gastrointestinal Stromal Tumor After Failure of Standard Therapy (NCT04258956) | Maria Sklodowska-Curie National Research Institute of Oncology | 2019-04-30 |
| PDR001 Plus Imatinib for Metastatic or Unresectable GIST (NCT03609424) | Asan Medical Center | 2019-02-14 |
| A Study of Ripretinib vs Sunitinib in Advanced GIST Patients After Treatment With Imatinib (NCT03673501) | Deciphera Pharmaceuticals, LLC | 2019-02-08 |
| Efficacy and Safety of Anlotinib in Patients With Advanced Gastrointestinal Stromal Tumor After Failure of Imatinib: a Prospective, Single Arm and Multicenter Trial (NCT04106024) | Cttq | 2018-10-23 |
| Observational Registry Data on GIST Patients (NCT03602092) | National Health Research Institutes, Taiwan | 2018-10-16 |
| Temozolomide (TMZ) In Advanced Succinate Dehydrogenase (SDH)-Mutant/Deficient Gastrointestinal Stromal Tumor (GIST) (NCT03556384) | Adam Burgoyne, MD, PhD | 2018-09-12 |
| Laparoscopic Endoscopic Cooperative Surgery in the Treatment of Gastric Stromal Tumors (NCT03601234) | First Affiliated Hospital Xi'an Jiaotong University | 2018-04-16 |
| Phase 3 Study of DCC-2618 vs Placebo in Advanced GIST Patients Who Have Been Treated With Prior Anticancer Therapies (NCT03353753) | Deciphera Pharmaceuticals, LLC | 2018-02-27 |
| A Phase II Trial of the DNA Methyl Transferase Inhibitor, Guadecitabine (SGI-110), in Children and Adults With Wild Type GIST,Pheochromocytoma and Paraganglioma Associated With Succinate Dehydrogenase Deficiency and HLRCC-associated Kidney Cancer (NCT03165721) | National Cancer Institute (NCI) | 2017-08-16 |
| A Study of BBI503 in Adult Patients With Advanced Gastrointestinal Stromal Tumors (NCT02232620) | Sumitomo Pharma America, Inc. | 2017-03-13 |
| SARC029: Trametinib and Pazopanib in Patients With GIST (Gastrointestinal Stromal Tumor) (NCT02342600) | Sarcoma Alliance for Research through Collaboration | 2017-01-01 |
| MITIGATE-NeoBOM: A Study to Evaluate 68Ga- NeoBOMB1 in Patients With Advanced TKI-treated GIST Using PET/CT (NCT02931929) | Medical University Innsbruck | 2016-11-28 |
| EUS-FNB vs. Single-incision Needle-knife (SINK) Biopsy for Gastrointestinal SELs (NCT02866045) | Unity Health Toronto | 2016-05-01 |
| The Effects of the Proton Pump Inhibitor Esomeprazole on the Bioavailability of Regorafenib (NCT02800330) | Erasmus Medical Center | 2016-05-01 |
| Single Agent Regorafenib in First-line for Metastatic/Unresectable KIT/PDGFR Wild Type GIST (NCT02638766) | Grupo Espanol de Investigacion en Sarcomas | 2015-11-01 |
| A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced Malignancies (NCT02571036) | Deciphera Pharmaceuticals, LLC | 2015-11-01 |
| Paclitaxel in Patients With Metastatic or Advanced Gastrointestinal Stromal Tumors (GIST) After Failure to Imatinib and Sunitinib (NCT02607332) | Asan Medical Center | 2015-11-01 |
| CGT9486 (Formerly Known as PLX9486) as a Single Agent and in Combination With PLX3397 (Pexidartinib) or Sunitinib in Participants With Advanced Solid Tumors (NCT02401815) | Cogent Biosciences, Inc. | 2015-03-06 |
| Dovitinib in Combination With Imatinib in Patients With Gastrointestinal Stromal Tumors (NCT02268435) | Asan Medical Center | 2015-03-01 |
| Endoscopic Full Thickness Resection of Gastric Subepithelial Tumors (FROST) (NCT02488746) | Kliniken Ludwigsburg-Bietigheim gGmbH | 2015-03-01 |
| Efficiency of Imatinib Treatment Maintenance or Interruption After 3 Years of Adjuvant Treatment in Patients With Gastrointestinal Stromal Tumours (GIST) (NCT02260505) | Centre Leon Berard | 2014-12-24 |
| A Real-world Comparison of FNB and FNA in IHC-required Lesions. (NCT05565066) | Huazhong University of Science and Technology | 2014-12-01 |
| A Retrospective Pharmacokinetics and Pharmacogenomics Research of Imatinib in Gastrointestinal Stromal Tumor Treatment (NCT03092128) | Xueding Wang | 2014-06-01 |
| Salvage Surgery for Patients With Metastatic GIST With Rego (NCT04343456) | Chang Gung Memorial Hospital | 2014-01-01 |
| Integrated Cancer Repository for Cancer Research (NCT02012699) | University of Nebraska | 2013-11-01 |
| Regorafenib Post-marketing Surveillance in Japan (NCT01933958) | Bayer | 2013-09-04 |
| Nilotinib Roll-over Protocol for Patients in Novartis-sponsored Nilotinib Study and Benefiting From Nilotinib Treatment (NCT01863745) | Novartis Pharmaceuticals | 2013-06-25 |
| A Study of Sunitinib In Young Patients With Advanced Gastrointestinal Stromal Tumor (NCT01396148) | Pfizer | 2012-06-01 |
| Masitinib in Patients With Gastrointestinal Stromal Tumour After Progression With Imatinib (NCT01694277) | AB Science | 2012-04-01 |
| Imatinib Dose Escalation to 800 mg/Day in Korean Patients With Metastatic or Unresectable GIST Harboring KIT Exon 9 Mutation: KENEDI (NCT01541709) | Asan Medical Center | 2012-03-01 |
| Pazopanib in Advanced Gastrointestinal Stromal Tumors Refractory to Imatinib and Sunitinib (NCT01524848) | Scandinavian Sarcoma Group | 2012-02-01 |
| Efficacy and Safety of Dovitinib in Patients With Gastrointestinal Stromal Tumors Refractory and/or Intolerant to Imatinib (NCT01478373) | Novartis Pharmaceuticals | 2012-01-01 |
| Caphosol in Oral Mucositis Due to Targeted Therapy (NCT01265810) | Impaqtt Foundation | 2011-11-01 |
| Detection of CF-DNA in Patients With Gastrointestinal Stromal Tumors (GIST) (NCT01462994) | Technical University of Munich | 2011-11-01 |
| Dovitinib for Imatinib/Sumitinib-failed Gastrointestinal Stromal Tumors (GIST): TKI258 (NCT01440959) | Asan Medical Center | 2011-09-01 |
| The Effects of Preoperative and Postoperative Oral Nutritional Supplements in Malnourished Post-gastrectomy Patients (NCT01421680) | Seoul National University Hospital | 2011-08-01 |
| Dose-Escalation Study of TH-302 in Combination With Sunitinib to Treat Patients With Advanced Renal Cell Carcinoma,Gastrointestinal Stromal Tumors and Pancreatic Neuroendocrine Tumors (NCT01381822) | Threshold Pharmaceuticals | 2011-06-01 |
| Study of Regorafenib as a 3rd-line or Beyond Treatment for Gastrointestinal Stromal Tumors (GIST) (NCT01271712) | Bayer | 2011-01-04 |
| WB-DWI for Early Prediction of Therapy Response in Patients With Advanced Metastatic GIST Treated With Regorafenib (NCT01265979) | Universitaire Ziekenhuizen KU Leuven | 2011-01-01 |
| Study to Evaluate the Pharmacokinetic Characteristics of Luckyvec 400mg Tablet, in Healthy Subjects (NCT01270984) | Chong Kun Dang Pharmaceutical | 2010-11-01 |
| Symptom Inventory for Gastrointestinal Stromal Tumors (NCT01178307) | M.D. Anderson Cancer Center | 2010-07-29 |
| Rechallenge of Imatinib in GIST Having no Effective Treatment: RIGHT (NCT01151852) | Asan Medical Center | 2010-06-01 |
| Study of Dose Escalation Versus no Dose Escalation of Imatinib in Metastatic Gastrointestinal Stromal Tumors (GIST) Patients (NCT01031628) | Sarcoma Alliance for Research through Collaboration | 2010-01-01 |
| Sorafenib for Imatinib/Sunitinib-failed GIST (NCT01091207) | Samsung Medical Center | 2009-11-01 |
| Nilotinib 800 Mg And Imatinib 800 Mg For The Treatment Of Patients With Gastrointestinal Stromal Tumors (Gist) Refractory To Imatinib 400 Mg (NCT00751036) | Novartis Pharmaceuticals | 2009-06-01 |
| Nilotinib Pharmacokinetics (PK) in Gastrointestinal Stromal Tumor (GIST): Nilotinib PK (NCT00976612) | Asan Medical Center | 2009-01-01 |
| Masitinib in First Line Treatment of Gastro-Intestinal Stromal Tumor (GIST) (NCT00812240) | AB Science | 2009-01-01 |
| Efficacy of Nilotinib in Adult Patients With Gastrointestinal Stromal Tumors Resistant to Imatinib and Sunitinib. (NCT01289028) | Novartis Pharmaceuticals | 2008-11-01 |
| Impact of the Inhibitors of Tyrosine Kinase on the Male Fertility (NCT01114087) | Assistance Publique - Hôpitaux de Paris | 2008-10-01 |
| Efficacy and Safety of AMN107 in Patients With GastroIntestinal Stromal Tumors (GIST) Who Have Failed Both Imatinib and Sunitinib (NCT00718562) | Novartis Pharmaceuticals | 2008-09-01 |
| Treatment of Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumors in First Line With Nilotinib (NCT00756509) | Novartis Pharmaceuticals | 2008-08-29 |
| Study Evaluating IPI-504 in Patients With Gastrointestinal Stromal Tumors (GIST) Following Failure of at Least Imatinib and Sunitinib (NCT00688766) | Infinity Pharmaceuticals, Inc. | 2008-08-01 |
| Safety and Efficacy Evaluation of Two Year Imatinib Treatment in Adjuvant Gastrointestinal Stromal Tumor (GIST) (NCT01172548) | Novartis Pharmaceuticals | 2008-08-01 |
| Nilotinib in Advanced Gastrointestinal Stromal Tumors (GIST) (NCT00782834) | Fox Chase Cancer Center | 2008-07-01 |
| Phase ll Study of Imatinib Mesylate for the Neoadjuvant Treatment of Patients With Gastrointestinal Stromal Tumors (GIST) (NCT01483014) | Novartis Pharmaceuticals | 2008-06-01 |
| Laparoscopic Resection of Large Gastric Stromal Tumors (NCT02662478) | Medical Park Gaziantep Hospital | 2008-06-01 |
| Special Investigation For Gist Of Sunitinib Malate (Regulatory Post Marketing Commitment Plan). (NCT00716820) | Pfizer | 2008-04-01 |
| Current Management of Gastrointestinal Stromal Tumors (GIST) in the Region of Coquimbo (NCT00564265) | Cirujanos la Serena | 2008-01-01 |
| Treatment Patterns in Gastrointestinal Stromal Tumors in the Community Oncology Setting (NCT00877045) | SCRI Development Innovations, LLC | 2008-01-01 |
| A Phase 2 Study of XL820 in Adults With Advanced GIST Resistant to Imatinib and/or Sunitinib (NCT00570635) | Exelixis | 2007-12-01 |
| Study of Imatinib and Peginterferon α-2b in Gastrointestinal Stromal Tumor (GIST) Patients (NCT00585221) | University of Utah | 2007-07-01 |
| Efficacy and Safety of Nilotinib (AMN107) Compared With Current Treatment Options in Patients With GIST Who Have Failed Both Imatinib and Sunitinib (NCT00471328) | Novartis Pharmaceuticals | 2007-03-01 |
| Patients Completing Core Protocol (CAMN107A2103), Exhibiting Stable Disease (SD), Partial Response (PR) or Complete Response (CR) to Nilotinib in Combination With Imatinib (NCT00441155) | Novartis Pharmaceuticals | 2006-11-01 |
| The Biological Activity of Cediranib (AZD2171) in Gastro-Intestinal Stromal Tumours(GIST). (NCT00385203) | AstraZeneca | 2006-09-01 |
| Ph II Study of Perifosine Plus Gleevec for Patients With GIST (NCT00455559) | AEterna Zentaris | 2006-08-01 |
| A Retrospective Clinical Records Review of Patients Diagnosed With Gastrointestinal Stromal Tumour at Two Tertiary Institutes in Singapore (NCT00718211) | National University Hospital, Singapore | 2006-05-01 |
| Safety Study of IPI-504 in Patients With Gastrointestinal Stromal Tumors (GIST) or Soft Tissue Sarcomas (STS) (NCT00276302) | Infinity Pharmaceuticals, Inc. | 2005-12-01 |
| Gastrointestinal Stromal Tumors (GIST) Registry (NCT00507273) | M.D. Anderson Cancer Center | 2005-08-01 |
| Study of AMN107 With Imatinib in Gastrointestinal Stromal Tumors (GIST) (NCT00135005) | Novartis Pharmaceuticals | 2005-08-01 |
| Gleevec Administered Preoperatively to Reduce Gastrointestinal Stromal Tumor (GIST) (NCT00290485) | Maisonneuve-Rosemont Hospital | 2005-08-01 |
| Adjuvant Imatinib in High-risk Gastrointestinal Stromal Tumor (GIST) With C-kit Mutation (NCT00278876) | Asan Medical Center | 2005-04-01 |
| A Phase I/II Study of Sunitinib Malate (SU011248) In Patients With Gastrointestinal Stromal Tumor (GIST) (NCT00457743) | Pfizer | 2005-01-01 |
| Post-Marketing Clinical Study of Postoperative Adjuvant Therapy With Imatinib Mesylate in Patients With Gastrointestinal Stromal Tumors (GIST) (NCT00171977) | Novartis Pharmaceuticals | 2004-07-01 |
| Open-label Trial of GlivecWith Unresectable or Metastatic Malignant Gastrointestinal Stromal Tumors (NCT00293124) | Central European Cooperative Oncology Group | 2004-03-01 |
| Preoperative and Postoperative Imatinib Mesylate Study in Patients With c-Kit Positive GIST (NCT00500188) | M.D. Anderson Cancer Center | 2003-07-01 |
| Everolimus in Combination With Imatinib in Patients With Glivec Refractory/Resistant Gastrointestinal Stromal Tumors (NCT01275222) | Novartis Pharmaceuticals | 2002-11-13 |
| Phase II Clinical Study of Imatinib Mesylate in Patients With Malignant Gastrointestinal Stromal Tumors (Extension Study) (NCT00237172) | Novartis Pharmaceuticals | 2002-09-01 |